<DOC>
	<DOCNO>NCT01444846</DOCNO>
	<brief_summary>Exposure loud sound cause hearing loss . The purpose research study evaluate potential prevention temporary change hear may occur listen music iPod personal music player . We measure temporary change hear subject listen music take either study drug , SPI-1005 , placebo 4 day . SPI-1005 proprietary preparation ebselen allow take mouth . Ebselen contain mineral selenium behaves like Glutathione Peroxidase , enzyme help rid body damaging chemical cause loud sound .</brief_summary>
	<brief_title>Otoprotection With SPI-1005 Prevention Temporary Auditory Threshold Shift</brief_title>
	<detailed_description />
	<mesh_term>Ebselen</mesh_term>
	<criteria>Healthy subject time enrollment . Each subject give inform consent participate study agree treatment protocol . Each subject interview regard hear health reveal history hearing loss , tinnitus , know ear pathology , use potentially ototoxic medication ( i.e . diuretic , minocycline ) . Nonoccupational sound exposure ( e.g. , concert , firearm , firework , power tool ) avoid 24hour period precede baseline test throughout duration study . Subjects vital sign ( i.e. , heart rate , blood pressure , respiration , temperature ) within normal limit upon medical examination . Subjects must normal audiologic assessment baseline consisting : Baseline audiometric evaluation confirms subject symmetric hear air conduction threshold worse 25 decibel Hearing Loss ( dBHL ) frequencies 0.25 8 kilo Hertz ( kHz ) bilaterally . No significant threshold asymmetry ( i.e . great 15 dB ) ears tested frequency . No significant airbone gap ( i.e . great 10 dB ) Type A tympanograms bilaterally , define range 140 +40 dekaPascals ( daPa ) base 90 % range adult ( Margolis Hunter 2000 ) â€¢ Subjects abnormal hearing level &gt; 25 dBHL test frequency ( 250 , 500 , 1000 , 2000 , 3000 , 4000 , 6000 8000 Hz ) either ear . Exposure duration nonoccupational highlevel sound ( e.g. , concert , firearm , firework , power tool ) 24 hour period precede baseline audiometric test reveal subject questionnaire medical examination . Pathology external ear discover upon otoscopic examination . Pathology middle ear reveal otoscopic examination , abnormal tympanometry , report history middle ear problem . Pathology inner ear auditory nerve reveal reported history . Subject complaint aural pain , pressure , fullness , drainage . Subjects test positive pregnancy exclude study . Subjects medical/health issue would preclude voluntary participation drug study may exclude discretion Principal Investigator . Subjects previously receive know potentially ototoxic medication . This include , limited , high dose salicylate ( &gt; 2 g/day ) , platinumbased chemotherapeutics aminoglycoside antibiotic , streptomycin , gentamicin , tobramycin , amikacin , neomycin , netilmycin . Subjects currently use potentially ototoxic medication ( i.e . diuretic minocycline ) . Subjects received investigational treatment ( drug device ) six month prior study . Subjects exhibit selfreporting shortness breath , wheeze , cough , hemoptysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>31 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Temporary Auditory Threshold Shift</keyword>
	<keyword>Hearing Loss</keyword>
	<keyword>Deafness</keyword>
	<keyword>SPI-1005</keyword>
	<keyword>Ebselen</keyword>
</DOC>